Head and Neck Cancer Patients Need Coordinated Survivorship Care Planning
Improving oropharyngeal cancer survival rates necessitates better coordination of survivorship care between oncology teams and primary care providers, according to a presentation at ONS. (Source: CancerNetwork)
Source: CancerNetwork - May 6, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Head & Neck Cancer News Conferences/ONS 2017 Source Type: news
New ASTRO Guidelines for Oropharyngeal Cancer
In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 27, 2017 Category: Cancer & Oncology Authors: David Sher, MD Tags: Head & Neck Cancer Radiation Oncology Source Type: news
Management of Oropharyngeal Cancer in the HPV Era Management of Oropharyngeal Cancer in the HPV Era
The incidence of head and neck cancer associated with HPV has increased at an epidemic rate. Review prevention and management strategies here.Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
ASTRO Releases First Guidelines for Oropharyngeal Cancer ASTRO Releases First Guidelines for Oropharyngeal Cancer
ASTRO releases its first guidelines for the management of oropharyngeal cancer but purposefully avoids distinguishing between HPV-positive and -negative disease despite differences in prognosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Immunovaccine starts dosing in Phase Ib/II trial of DPX-E7 to treat HPV-related cancers
Canadian-based biopharmaceutical company Immunovaccine has started dosing patients in a Phase Ib/II trial of its vaccine DPX-E7 for the treatment of incurable human papillomavirus (HPV) related oropharyngeal, cervical and anal cancers. (Source: Drug Development Technology)
Source: Drug Development Technology - April 18, 2017 Category: Pharmaceuticals Source Type: news
ASTRO Guideline for Oropharyngeal Cancer Reflects Changes (CME/CE)
(MedPage Today) -- Less aggressive treatment for less aggressive disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 18, 2017 Category: Hematology Source Type: news
ASTRO releases oropharyngeal cancer guidelines
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline...Read more on AuntMinnie.comRelated Reading:
ASTRO partners with ASCO's CancerLinQ
ASTRO updates guidelines on painful bone metastases
Elekta to support ASTRO safety initiative
ASTRO releases updated APBI guide
ASTRO: PET predicts outcomes in vulvar cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2017 Category: Radiology Source Type: news
New ASTRO Guideline Establishes Standard of Care for Curative Treatment of Oropharyngeal Cancer with Radiation Therapy
ARLINGTON, Va., April 17, 2017 -- (Healthcare Sales & Marketing Network) -- The American Society for Radiation Oncology (ASTRO) today issued a new clinical guideline for the management of oropharyngeal cancer. The guideline, "Radiation therapy for or... Devices, Oncology American Society for Radiation Oncology, radiotherapy, oropharyngeal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2017 Category: Pharmaceuticals Source Type: news
Guideline sets standard of care for treatment of oropharynx cancer with radiation therapy
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) today issued a new clinical guideline for the management of oropharyngeal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2017 Category: Cancer & Oncology Source Type: news
Robotic Surgery Thrifty Option in Oropharyngeal Cancer Robotic Surgery Thrifty Option in Oropharyngeal Cancer
Treatment of oropharyngeal cancer with transoral robotic surgery (TORS) may offer advantages over traditional approaches, researchers say.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Survival Worse in Patients With Rare Oropharyngeal Small-Cell Carcinoma
Oropharyngeal small-cell carcinoma was more likely to present as distant disease and was associated with worse survival outcomes compared with squamous cell carcinoma, according to new research. (Source: CancerNetwork)
Source: CancerNetwork - April 8, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Head & Neck Cancer News Source Type: news
A biomarker for cancer of the oropharynx
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) A growing number of cases of oropharyngeal cancer are considered to be a consequence of infection with human papillomaviruses (HPV). Scientists at the German Cancer Research Center (DKFZ) have now revealed that a single blood sample test for specific antibodies can identify persons who are at a high risk of developing this type of cancer ten years or more before cancer diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 3, 2017 Category: Cancer & Oncology Source Type: news
Ohio State joins national call for HPV vaccination as a means of preventing cancer
(Ohio State University Wexner Medical Center) Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers, vaccination rates remain low across the US, with just 41.9 percent of girls and 28.1 percent of boys completing the recommend vaccine series. papillomavirus (HPV). The nation's National Cancer Institute-designated cancer centers have joined together to issue a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 11, 2017 Category: Cancer & Oncology Source Type: news
Reducing radiation successfully treats HPV-positive oropharynx cancers and minimizes side effects
Human papillomavirus-positive oropharynx cancers (cancers of the tonsils and back of the throat) are on rise. After radiation treatment, patients often experience severe, lifelong swallowing, eating, and nutritional issues. However, new clinical trial research shows reducing radiation for some patients with HPV-associated oropharyngeal squamous cell carcinomas can maintain high cure rates while sparing some of these late toxicities. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 27, 2016 Category: Science Source Type: news
Predicting throat cancer recurrence with a blood test
Researchers found that patients whose oropharyngeal cancer recurred had higher levels of antibodies for two proteins, E6 and E7, which are found in HPV-fueled cancers. The finding suggests a potential blood-based marker that could predict when cancer is likely to return. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 15, 2016 Category: Science Source Type: news
